scholarly article | Q13442814 |
P50 | author | John Hiscott | Q28322441 |
Damien Vitour | Q37342117 | ||
Rongtuan Lin | Q47696091 | ||
Peyman Nakhaei | Q92260476 | ||
P2093 | author name string | Peter Wilkinson | |
Ilkka Julkunen | |||
Qiang Sun | |||
Long Yang | |||
Judith Lacoste | |||
Suzanne Paz | |||
Eliane Meurs | |||
P2860 | cites work | Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity | Q24296473 |
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction | Q24318426 | ||
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus | Q24336255 | ||
Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon | Q24519072 | ||
CARD games in apoptosis and immunity | Q24522647 | ||
Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation | Q24523761 | ||
mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties | Q24530264 | ||
Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I | Q24556673 | ||
The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter | Q24558779 | ||
Toll-like receptor signalling | Q24570126 | ||
Stealth and cunning: hepatitis B and hepatitis C viruses | Q27470232 | ||
Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture | Q27473339 | ||
Efficient initiation of HCV RNA replication in cell culture | Q27860520 | ||
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses | Q27860685 | ||
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome | Q27860719 | ||
Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3 | Q27860854 | ||
Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3 | Q27861127 | ||
VISA is an adapter protein required for virus-triggered IFN-beta signaling | Q28131814 | ||
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway | Q28190704 | ||
Triggering the interferon antiviral response through an IKK-related pathway | Q28191761 | ||
Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF | Q29547901 | ||
Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling | Q29614206 | ||
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus | Q29614207 | ||
Epidemiology of hepatitis C: geographic differences and temporal trends | Q29615896 | ||
Cell type-specific involvement of RIG-I in antiviral response | Q29615914 | ||
Immunology of hepatitis B virus and hepatitis C virus infection | Q29618957 | ||
Evasion of intracellular host defence by hepatitis C virus | Q29618976 | ||
Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome | Q29620780 | ||
To interfere and to anti-interfere: the interplay between hepatitis C virus and interferon. | Q30330124 | ||
Structure and function of the interferon-beta enhanceosome | Q33671579 | ||
The IFN-beta enhancer: a paradigm for understanding activation and repression of inducible gene expression | Q34170652 | ||
Multiple roles of CLAN (caspase-associated recruitment domain, leucine-rich repeat, and NAIP CIIA HET-E, and TP1-containing protein) in the mammalian innate immune response | Q34365418 | ||
Recent advances in the molecular biology of hepatitis C virus | Q34417709 | ||
IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts | Q35122228 | ||
CARD proteins as therapeutic targets in cancer | Q35767913 | ||
Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection | Q36266285 | ||
The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection | Q36402648 | ||
Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection | Q36402672 | ||
Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability | Q36557754 | ||
Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. | Q39455009 | ||
Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. | Q40348165 | ||
Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA. | Q40678254 | ||
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus | Q42987918 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | virus | Q808 |
virology | Q7215 | ||
proteolysis | Q33123 | ||
mitochondrion | Q39572 | ||
hepatitis C | Q154869 | ||
Hepatitis C virus | Q708693 | ||
P304 | page(s) | 6072-83 | |
P577 | publication date | 2006-06-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage | |
P478 | volume | 80 |
Q35861251 | A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice |
Q38857831 | A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response |
Q35606341 | Activation and evasion of antiviral innate immunity by hepatitis C virus. |
Q35847364 | Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus |
Q56395782 | Adaptive mutation F772S-enhanced p7-NS4A cooperation facilitates the assembly and release of hepatitis C virus and is associated with lipid droplet enlargement |
Q36948514 | Altered innate immunity in chronic hepatitis C infection: cause or effect? |
Q35775805 | Alternative ferritin mRNA translation via internal initiation |
Q24305205 | Ankrd17 positively regulates RIG-I-like receptor (RLR)-mediated immune signaling |
Q40285838 | Arenavirus nucleoproteins prevent activation of nuclear factor kappa B. |
Q45324910 | Avian infectious bronchitis virus disrupts the melanoma differentiation associated gene 5 (MDA5) signaling pathway by cleavage of the adaptor protein MAVS. |
Q80199717 | Bax-dependent mitochondrial membrane permeabilization enhances IRF3-mediated innate immune response during VSV infection |
Q59349462 | Camouflage and interception: How pathogens evade detection by intracellular nucleic acid sensors |
Q24306554 | Central role of interferon regulatory factor-1 (IRF-1) in controlling retinoic acid inducible gene-I (RIG-I) expression |
Q34152661 | Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling |
Q35620170 | Dengue Virus NS Proteins Inhibit RIG-I/MAVS Signaling by Blocking TBK1/IRF3 Phosphorylation: Dengue Virus Serotype 1 NS4A Is a Unique Interferon-Regulating Virulence Determinant |
Q38419101 | Early IFN type I response: Learning from microbial evasion strategies |
Q34361091 | Ebselen inhibits hepatitis C virus NS3 helicase binding to nucleic acid and prevents viral replication |
Q33799276 | Elimination of hepatitis C virus from hepatocytes by a selective activation of therapeutic molecules |
Q34649632 | Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses |
Q40014093 | Essential role of the N-terminal domain in the regulation of RIG-I ATPase activity |
Q36587775 | Foot-and-mouth disease virus non-structural protein 3A inhibits the interferon-β signaling pathway |
Q24632537 | Function and regulation of retinoic acid-inducible gene-I |
Q36774929 | Function of RIG-I-like receptors in antiviral innate immunity |
Q40173025 | Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense |
Q35190533 | Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity |
Q24675888 | GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS |
Q37547038 | Hantavirus GnT elements mediate TRAF3 binding and inhibit RIG-I/TBK1-directed beta interferon transcription by blocking IRF3 phosphorylation |
Q40141993 | Hepatitis C Virus NS5A Targets Nucleosome Assembly Protein NAP1L1 To Control the Innate Cellular Response |
Q39621458 | Hepatitis C virus NS2 coordinates virus particle assembly through physical interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes |
Q24297286 | Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity |
Q28473895 | Hepatitis C virus controls interferon production through PKR activation |
Q40099643 | Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy |
Q35728873 | Hepatitis C virus infection: establishment of chronicity and liver disease progression |
Q24310415 | Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines |
Q24563969 | Hepatitis C virus proteins |
Q40375851 | Herpes Simplex Virus 1 Abrogates the cGAS/STING-Mediated Cytosolic DNA-Sensing Pathway via Its Virion Host Shutoff Protein, UL41. |
Q36950870 | Herpes Simplex Virus 1 Serine Protease VP24 Blocks the DNA-Sensing Signal Pathway by Abrogating Activation of Interferon Regulatory Factor 3. |
Q64273918 | Herpes Simplex Virus 1 Tegument Protein UL46 Inhibits TANK-Binding Kinase 1-Mediated Signaling |
Q59360636 | Herpes Simplex Virus 1 Tegument Protein VP22 Abrogates cGAS/STING-Mediated Antiviral Innate Immunity |
Q40366513 | Herpes Simplex Virus 1 UL24 Abrogates the DNA Sensing Signal Pathway by Inhibiting NF-κB Activation |
Q40392310 | Herpes Simplex Virus 1 Ubiquitin-Specific Protease UL36 Abrogates NF-κB Activation in DNA Sensing Signal Pathway |
Q37336521 | Herpes simplex virus 1 serine/threonine kinase US3 hyperphosphorylates IRF3 and inhibits beta interferon production. |
Q24304261 | Herpes simplex virus 1 tegument protein US11 downmodulates the RLR signaling pathway via direct interaction with RIG-I and MDA-5 |
Q37252761 | Herpes simplex virus 1 ubiquitin-specific protease UL36 inhibits beta interferon production by deubiquitinating TRAF3. |
Q37123477 | Herpes simplex virus 1-encoded tegument protein VP16 abrogates the production of beta interferon (IFN) by inhibiting NF-κB activation and blocking IFN regulatory factor 3 to recruit its coactivator CBP. |
Q24319001 | IFN-induced TPR protein IFIT3 potentiates antiviral signaling by bridging MAVS and TBK1 |
Q34193137 | Identification of DreI as an antiviral factor regulated by RLR signaling pathway |
Q24304438 | Immune signaling by RIG-I-like receptors |
Q50934385 | Immunopathogenesis of Hepatitis C Virus Infection. |
Q30417679 | Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential |
Q24311228 | Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus |
Q26773329 | Innate Immunity and Immune Evasion by Enterovirus 71 |
Q38170229 | Innate antiviral immune signaling, viral evasion and modulation by HIV-1. |
Q34075737 | Innate host response in primary human hepatocytes with hepatitis C virus infection |
Q38394763 | Insights into antiviral innate immunity revealed by studying hepatitis C virus. |
Q34660504 | Interferon, Mx, and viral countermeasures |
Q37342272 | Interferons: signaling, antiviral and viral evasion |
Q39445379 | IκB kinase ε-dependent phosphorylation and degradation of X-linked inhibitor of apoptosis sensitizes cells to virus-induced apoptosis |
Q40103042 | Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes |
Q57460640 | Low level expression of the Mitochondrial Antiviral Signaling protein (MAVS) associated with long-term nonprogression in SIV-infected rhesus macaques |
Q37051657 | MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease |
Q64247444 | MAVS polymers smaller than 80 nm induce mitochondrial membrane remodeling and interferon signaling |
Q36637910 | Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses |
Q34799187 | Mitochondria in innate immune responses |
Q91981908 | Mitochondrial Dysfunction and the Aging Immune System |
Q37274214 | Mitochondrial factors in the regulation of innate immunity |
Q35197999 | Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus |
Q37863124 | Mitochondrion: an emerging platform critical for host antiviral signaling |
Q35205924 | Mitoxosome: a mitochondrial platform for cross-talk between cellular stress and antiviral signaling. |
Q28383150 | Modulation of Mitochondrial Antiviral Signaling by Human Herpesvirus 8 Interferon Regulatory Factor 1 |
Q28482890 | New details of HCV NS3/4A proteinase functionality revealed by a high-throughput cleavage assay |
Q27478093 | New pandemics: HIV and AIDS, HCV and chronic hepatitis, influenza virus and flu |
Q56395741 | Nuclear-resident RIG-I senses viral replication inducing antiviral immunity |
Q34725292 | Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses |
Q41676295 | Picornaviruses and Apoptosis: Subversion of Cell Death |
Q39834740 | Polo-like kinase 1 (PLK1) regulates interferon (IFN) induction by MAVS. |
Q41897776 | Poly(C)-binding protein 1 (PCBP1) mediates housekeeping degradation of mitochondrial antiviral signaling (MAVS) |
Q97527142 | Porcine Deltacoronavirus Accessory Protein NS7a Antagonizes IFN-β Production by Competing With TRAF3 and IRF3 for Binding to IKKε |
Q28543776 | Proteomic analysis of mitochondrial-associated ER membranes (MAM) during RNA virus infection reveals dynamic changes in protein and organelle trafficking |
Q38797027 | Quantitative microspectroscopic imaging reveals viral and cellular RNA helicase interactions in live cells |
Q37344605 | RIG-I is cleaved during picornavirus infection |
Q34150344 | RIG-I-Mediated Antiviral Signaling Is Inhibited in HIV-1 Infection by a Protease-Mediated Sequestration of RIG-I |
Q36306301 | RNA binding by the NS3 protease of the hepatitis C virus |
Q24673649 | RNA- and virus-independent inhibition of antiviral signaling by RNA helicase LGP2 |
Q24298373 | Recruitment of an interferon molecular signaling complex to the mitochondrial membrane: disruption by hepatitis C virus NS3-4A protease |
Q26824743 | Regulation of hepatic innate immunity by hepatitis C virus |
Q93096532 | Regulation of signaling mediated by nucleic acid sensors for innate interferon-mediated responses during viral infection |
Q90670400 | Regulation of virus-triggered type I interferon signaling by cellular and viral proteins |
Q33598593 | Requirement of NOX2 and reactive oxygen species for efficient RIG-I-mediated antiviral response through regulation of MAVS expression |
Q36922870 | Retinoic acid inducible gene-I, more than a virus sensor |
Q42824244 | Rig-I-/- mice develop colitis associated with downregulation of G alpha i2. |
Q38198455 | Role of pattern recognition receptors in flavivirus infections |
Q21090517 | Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonism |
Q36539000 | SARS coronavirus and innate immunity |
Q42624738 | Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane |
Q30484693 | Signaling network of dendritic cells in response to pathogens: a community-input supported knowledgebase |
Q26700073 | Simultaneously Targeting the NS3 Protease and Helicase Activities for More Effective Hepatitis C Virus Therapy |
Q39044882 | Spontaneous NF-κB activation by autocrine TNFα signaling: a computational analysis |
Q37560797 | Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes |
Q27481029 | The C Terminus of Hepatitis C Virus NS4A Encodes an Electrostatic Switch That Regulates NS5A Hyperphosphorylation and Viral Replication |
Q24314976 | The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation |
Q40139227 | The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways |
Q36898687 | The NY-1 hantavirus Gn cytoplasmic tail coprecipitates TRAF3 and inhibits cellular interferon responses by disrupting TBK1-TRAF3 complex formation |
Q42170036 | The acidic domain of hepatitis C virus NS4A contributes to RNA replication and virus particle assembly |
Q24316038 | The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation |
Q46404646 | The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases |
Q36841738 | The interferon inducing pathways and the hepatitis C virus |
Q38307247 | The protein kinase IKKepsilon can inhibit HCV expression independently of IFN and its own expression is downregulated in HCV-infected livers |
Q40863011 | The role of immunostimulatory nucleic acids in septic shock |
Q33869369 | The role of mitochondria in the mammalian antiviral defense system |
Q24321482 | The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA |
Q27489687 | Toll-Like Receptor 3 Mediates Establishment of an Antiviral State against Hepatitis C Virus in Hepatoma Cells |
Q37051007 | Toll-like receptors and immune regulation: implications for cancer therapy |
Q36898663 | Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response |
Q39680564 | Tom70 mediates activation of interferon regulatory factor 3 on mitochondria |
Q37411480 | Transcriptional re-programming of primary macrophages reveals distinct apoptotic and anti-tumoral functions of IRF-3 and IRF-7. |
Q36597749 | Two new monoclonal antibodies for biochemical and flow cytometric analyses of human interferon regulatory factor-3 activation, turnover, and depletion |
Q37233348 | Ubiquitin-regulated recruitment of IkappaB kinase epsilon to the MAVS interferon signaling adapter |
Q27481222 | Ubiquitination and proteasomal degradation of interferon regulatory factor-3 induced by Npro from a cytopathic bovine viral diarrhea virus |
Q28743826 | Varicella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3 |
Q37319381 | Viral evasion and subversion of pattern-recognition receptor signalling |
Q35619821 | Viral product trafficking to mitochondria, mechanisms and roles in pathogenesis |
Q36750723 | Viral suppression of the interferon system |
Q38626676 | Visual detection of Flavivirus RNA in living cells |
Q35089155 | Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon |
Q36432681 | dsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection |
Q40218590 | mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. |